According to a research report titled ‘Coronary Stents Market  Insights, Competitive Landscape and Market Forecast-2026’, available with Market Study Report, global coronary stents market is projected to record a remarkable compound annual growth rate through 2026.
 

As per the report findings, rising number of percutaneous coronary intervention (PCI) procedures coupled with ongoing technological advancements are augmenting worldwide coronary stents market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3557524/
 

Moreover, escalating demand for minimally invasive procedures, as well as development of bioresorbable vascular scaffold (BVS) are adding substantial traction to industry development.
 

For the unversed, coronary stents are stretchable tube-shaped devices that are used to expand arteries to arrest the formation of blockages. Some forms of coronary diseases are caused due to the build-up of plaque in arteries. Coronary stents can be used to expand narrowed arteries, thus reducing the possibility of heart attacks and other coronary disorders among patients.
 

On the downside, stringent product approval protocols, availability of alternate treatment methods for coronary artery diseases (CAD), and cases of product failure and recall are likely to hamper the demand in global coronary stents market in the upcoming years.
 

Classifying on the basis of product type, the industry is split into bare metal, drug-eluting, and bioabsorbable stents. By mode of delivery, the business vertical comprises balloon expandable, and self-expanding stents.
 

Moving on to the end-user spectrum, global coronary stents market is arrayed into cardiac centers, hospitals, and ambulatory surgical centers.
 

Elaborating on the geographical terrain, the EU5 (Germany, Italy, France, Spain, U.K.), Japan, and the U.S. are generating significant revenues in global coronary stents market.
 

The competitive landscape of the industry is defined by Biotronik SE & Co. KG, Elixir Medical Corp., B. Braun Melsungen AG, Terumo Corp., Stentys SA, Medtronic plc, Boston Scientific Corp., Translumina GmbH, Abbott Laboratories, and Reva Medical LLC.